Westlake Village BioPartners Launches Two New Funds Totaling $500 Million to Advance Transformative Treatments
Since its founding in 2018, Westlake Village BioPartners has raised more than $820 million
Westlake s location, focus on building biotech companies, and scale are catalyzing the burgeoning Los Angeles Biotech Hub
News provided by
Share this article
LOS ANGELES, Dec. 15, 2020 /PRNewswire/
Westlake Village BioPartners today announced the launch of two new funds totaling $500 million to build and invest in promising life sciences companies with transformative human therapeutic technologies.
The first fund, known as Opportunity 1, is $70 million and allows Westlake to invest additional Series B or later-round capital into promising companies they incubated or invested in with their original fund, Westlake BioPartners 1 (WBP1). One example is an early stage biotechnology company focused on developing precision medicines for genetically defined neurological and immunolo